These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

200 related items for PubMed ID: 30291846

  • 1. Overexpression of Desmoglein 2 in a Mouse Model of Gorlin Syndrome Enhances Spontaneous Basal Cell Carcinoma Formation through STAT3-Mediated Gli1 Expression.
    Brennan-Crispi DM, Overmiller AM, Tamayo-Orrego L, Marous MR, Sahu J, McGuinn KP, Cooper F, Georgiou IC, Frankfurter M, Salas-Alanis JC, Charron F, Millar SE, Mahoney MG, Riobo-Del Galdo NA.
    J Invest Dermatol; 2019 Feb; 139(2):300-307. PubMed ID: 30291846
    [Abstract] [Full Text] [Related]

  • 2. Crosstalk between Desmoglein 2 and Patched 1 accelerates chemical-induced skin tumorigenesis.
    Brennan-Crispi DM, Hossain C, Sahu J, Brady M, Riobo NA, Mahoney MG.
    Oncotarget; 2015 Apr 20; 6(11):8593-605. PubMed ID: 25871385
    [Abstract] [Full Text] [Related]

  • 3. Activation of the transcription factor Gli1 and the Sonic hedgehog signalling pathway in skin tumours.
    Dahmane N, Lee J, Robins P, Heller P, Ruiz i Altaba A.
    Nature; 1997 Oct 23; 389(6653):876-81. PubMed ID: 9349822
    [Abstract] [Full Text] [Related]

  • 4. Gli1 is important for medulloblastoma formation in Ptc1+/- mice.
    Kimura H, Stephen D, Joyner A, Curran T.
    Oncogene; 2005 Jun 09; 24(25):4026-36. PubMed ID: 15806168
    [Abstract] [Full Text] [Related]

  • 5. Several PATCHED1 missense mutations display activity in patched1-deficient fibroblasts.
    Bailey EC, Milenkovic L, Scott MP, Collawn JF, Johnson RL.
    J Biol Chem; 2002 Sep 13; 277(37):33632-40. PubMed ID: 12072433
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Expression of the Sonic Hedgehog receptor "PATCHED" in basal cell carcinomas and odontogenic keratocysts.
    Zedan W, Robinson PA, Markham AF, High AS.
    J Pathol; 2001 Aug 13; 194(4):473-7. PubMed ID: 11523056
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. A Novel Mechanism for Activation of GLI1 by Nuclear SMO That Escapes Anti-SMO Inhibitors.
    Rahman MM, Hazan A, Selway JL, Herath DS, Harwood CA, Pirzado MS, Atkar R, Kelsell DP, Linton KJ, Philpott MP, Neill GW.
    Cancer Res; 2018 May 15; 78(10):2577-2588. PubMed ID: 29463581
    [Abstract] [Full Text] [Related]

  • 11. Loss of correlation between intensities of desmoglein 2 and desmoglein 3 expression in basal cell carcinomas.
    Gornowicz-Porowska J, Bowszyc-Dmochowska M, Seraszek-Jaros A, Kaczmarek E, Dmochowski M.
    Acta Dermatovenerol Croat; 2011 May 15; 19(3):150-5. PubMed ID: 21933638
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Expression profile of sonic hedgehog signaling-related molecules in basal cell carcinoma.
    Kim HS, Kim YS, Lee C, Shin MS, Kim JW, Jang BG.
    PLoS One; 2019 May 15; 14(11):e0225511. PubMed ID: 31756206
    [Abstract] [Full Text] [Related]

  • 14. Anticancer drugs and the regulation of Hedgehog genes GLI1 and PTCH1, a comparative study in nonmelanoma skin cancer cell lines.
    Olesen UH, Bojesen S, Gehl J, Haedersdal M.
    Anticancer Drugs; 2017 Nov 15; 28(10):1106-1117. PubMed ID: 28799948
    [Abstract] [Full Text] [Related]

  • 15. Suprabasal Dsg2 expression in transgenic mouse skin confers a hyperproliferative and apoptosis-resistant phenotype to keratinocytes.
    Brennan D, Hu Y, Joubeh S, Choi YW, Whitaker-Menezes D, O'Brien T, Uitto J, Rodeck U, Mahoney MG.
    J Cell Sci; 2007 Mar 01; 120(Pt 5):758-71. PubMed ID: 17284515
    [Abstract] [Full Text] [Related]

  • 16. Expression of calretinin in odontogenic keratocysts and basal cell carcinomas: A study of sporadic and Gorlin-Goltz syndrome-related cases.
    Cesinaro AM, Burtini G, Maiorana A, Rossi G, Migaldi M.
    Ann Diagn Pathol; 2020 Apr 01; 45():151472. PubMed ID: 31982676
    [Abstract] [Full Text] [Related]

  • 17. Tumor-Derived Suppressor of Fused Mutations Reveal Hedgehog Pathway Interactions.
    Urman NM, Mirza A, Atwood SX, Whitson RJ, Sarin KY, Tang JY, Oro AE.
    PLoS One; 2016 Apr 01; 11(12):e0168031. PubMed ID: 28030567
    [Abstract] [Full Text] [Related]

  • 18. Constitutive activation of the shh-ptc1 pathway by a patched1 mutation identified in BCC.
    Barnes EA, Heidtman KJ, Donoghue DJ.
    Oncogene; 2005 Jan 27; 24(5):902-15. PubMed ID: 15592520
    [Abstract] [Full Text] [Related]

  • 19. Loss of protein kinase Calpha expression may enhance the tumorigenic potential of Gli1 in basal cell carcinoma.
    Neill GW, Ghali LR, Green JL, Ikram MS, Philpott MP, Quinn AG.
    Cancer Res; 2003 Aug 01; 63(15):4692-7. PubMed ID: 12907651
    [Abstract] [Full Text] [Related]

  • 20. Interaction between STAT3 and GLI1/tGLI1 oncogenic transcription factors promotes the aggressiveness of triple-negative breast cancers and HER2-enriched breast cancer.
    Sirkisoon SR, Carpenter RL, Rimkus T, Anderson A, Harrison A, Lange AM, Jin G, Watabe K, Lo HW.
    Oncogene; 2018 May 01; 37(19):2502-2514. PubMed ID: 29449694
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.